English

QUANTRX BIOMEDICAL CORPORATION

EDGAR

QTXB Quarterly report (10-Q) · filed 2022-11-14

121 filing records in this dataset, filed from 1995-08-14 to 2022-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2020 Q4 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-5.84 thousand USD

2020 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -74923 USD Source
Operating Cash Flow: -69085 USD Source

Cash and cash equivalents: 3.88 thousand USD 2022-09-30 Source
Exact value

3884 USD
Long-term debt including current maturities: 1.49 million USD 2021-12-31 Source
Exact value

1489694 USD
Shares outstanding: 78.7 million shares 2022-09-30 Source
Exact value

78696461 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

78696461 shares · 2021-09-30· Source
78696461 shares · 2022-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-261 thousand USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Net income: -260042 USD · 2021-01-01 – 2021-12-31 Source
Net income: -199003 USD · 2021-01-01 – 2021-09-30 Source
Net income: -57487 USD · 2022-01-01 – 2022-03-31 Source
Net income: -80815 USD · 2022-04-01 – 2022-06-30 Source
Net income: -61166 USD · 2022-07-01 – 2022-09-30 Source

Operating cash flow

-48.2 thousand USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Operating cash flow: -49478 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -34377 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -30 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -29304 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -30 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -33066 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -29304 USD · 2022-01-01 – 2022-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-11-14.

Financial data available through: 2020-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2020-12-31
Operating income: 11 of 11 periods available· newest 2020-12-31
Net income: 11 of 11 periods available· newest 2020-12-31
Operating cash flow: 11 of 11 periods available· newest 2020-12-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2020-12-31
Total liabilities: 11 of 11 periods available· newest 2020-12-31
Current assets: 11 of 11 periods available· newest 2020-12-31
Current liabilities: 11 of 11 periods available· newest 2020-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2020-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2020-12-31
Shares outstanding: 11 of 11 periods available· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2019-01-01 – 2019-12-31
Current period

USD 0

2020-01-01 – 2020-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
0 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · QUANTRX BIOMEDICAL CORPORATION · 2020-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495421004257/qtxb-20201231.xml#39096 Filing: 000165495421004257 Input fundies:Revenue: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495421004257/qtxb-20201231.xml#39206 Filing: 000165495421004257
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 369,186

Prior period

−USD 621,920

2019-01-01 – 2019-12-31
Current period

−USD 252,734

2020-01-01 – 2020-12-31

Exact inputs and evidence

-252734 − -621920 = 369186 USD

-621920 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
-252734 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · QUANTRX BIOMEDICAL CORPORATION · 2020-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Year-over-year change in Net income: 369186 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -252734 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000149315222010071/form10-k.htm#656491 Filing: 000149315222010071 Input fundies:NetIncome: -621920 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495421004257/qtxb-20201231.xml#42978 Filing: 000165495421004257
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 116,750

Prior period

−USD 191,673

2019-01-01 – 2019-12-31
Current period

−USD 74,923

2020-01-01 – 2020-12-31

Exact inputs and evidence

-74923 − -191673 = 116750 USD

-191673 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
-74923 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · QUANTRX BIOMEDICAL CORPORATION · 2020-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Year-over-year change in Operating cash flow: 116750 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -74923 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000149315222010071/form10-k.htm#607886 Filing: 000149315222010071 Input fundies:OperatingCashFlow: -191673 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495421004257/qtxb-20201231.xml#47318 Filing: 000165495421004257
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

Revenue USD 0
Operating costs Derived USD 60,624
Operating income −USD 60,624
Tax, interest and other Derived USD 192,110
Net income −USD 252,734

Cash

Operating cash flow −USD 74,923
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2011 Operating loss: operating costs were 4,275% of revenue.
2012 Operating loss: operating costs were 3,344% of revenue.
2013 Operating loss: operating costs were 6,267% of revenue.
2014 Operating loss: operating costs were 19,132% of revenue.
2015 Operating loss: operating costs were 230,042% of revenue.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2011 2011-01-01 – 2011-12-31	19085	815850 Derived	-796765	-13149 Derived	-783616	Unavailable	Source 2011-01-01 – 2011-12-31: 19085 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -796765 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -783616 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -427379 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	15236	509524 Derived	-494288	223679 Derived	-717967	Unavailable	Source 2012-01-01 – 2012-12-31: 15236 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -494288 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -717967 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -182101 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	6113	383074 Derived	-376961	-18630 Derived	-358331	Unavailable	Source 2013-01-01 – 2013-12-31: 6113 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -376961 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -358331 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -149532 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	2430	464912 Derived	-462482	364503 Derived	-826985	Unavailable	Source 2014-01-01 – 2014-12-31: 2430 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -462482 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -826985 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -291911 USD Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	156	358865 Derived	-358709	109071 Derived	-467780	Unavailable	Source 2015-01-01 – 2015-12-31: 156 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -358709 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -467780 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -226378 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	0	138839 Derived	-138839	259155 Derived	-397994	Unavailable	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -138839 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -397994 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -94643 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	0	165171 Derived	-165171	-1034310 Derived	869139	Unavailable	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -165171 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 869139 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -150613 USD Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	0	235879 Derived	-235879	500971 Derived	-736850	Unavailable	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -235879 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -736850 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -257920 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	0	201739 Derived	-201739	420181 Derived	-621920	Unavailable	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -201739 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -621920 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -191673 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	0	60624 Derived	-60624	192110 Derived	-252734	Unavailable	Source 2020-01-01 – 2020-12-31: 0 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -60624 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -252734 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -74923 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2020

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Revenue	19085	Revenue: 19085 Open source
20122012-12-31	Revenue	15236	Revenue: 15236 Open source
20132013-12-31	Revenue	6113	Revenue: 6113 Open source
20142014-12-31	Revenue	2430	Revenue: 2430 Open source
20152015-12-31	Revenue	156	Revenue: 156 Open source
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	0	Revenue: 0 Open source
20192019-12-31	Revenue	0	Revenue: 0 Open source
20202020-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Year over year	-70%	Revenue: 19085 Open source Revenue: 63717 Open source
20122012-12-31	Year over year	-20.2%	Revenue: 15236 Open source Revenue: 19085 Open source
20132013-12-31	Year over year	-59.9%	Revenue: 6113 Open source Revenue: 15236 Open source
20142014-12-31	Year over year	-60.2%	Revenue: 2430 Open source Revenue: 6113 Open source
20152015-12-31	Year over year	-93.6%	Revenue: 156 Open source Revenue: 2430 Open source
20162016-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 156 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192019-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20202020-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -229,941.7% 2015

Net margin -299,859% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Operating margin	-4,174.8%	Operating Income: -796765 Open source Revenue: 19085 Open source
20122012-12-31	Operating margin	-3,244.2%	Operating Income: -494288 Open source Revenue: 15236 Open source
20132013-12-31	Operating margin	-6,166.5%	Operating Income: -376961 Open source Revenue: 6113 Open source
20142014-12-31	Operating margin	-19,032.2%	Operating Income: -462482 Open source Revenue: 2430 Open source
20152015-12-31	Operating margin	-229,941.7%	Operating Income: -358709 Open source Revenue: 156 Open source
20162016-12-31	Operating margin	Not reported	Operating Income: -138839 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -165171 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -235879 Open source Revenue: 0 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -201739 Open source Revenue: 0 Open source
20202020-12-31	Operating margin	Not reported	Operating Income: -60624 Open source Revenue: 0 Open source
20112011-12-31	Net margin	-4,105.9%	Net Income: -783616 Open source Revenue: 19085 Open source
20122012-12-31	Net margin	-4,712.3%	Net Income: -717967 Open source Revenue: 15236 Open source
20132013-12-31	Net margin	-5,861.8%	Net Income: -358331 Open source Revenue: 6113 Open source
20142014-12-31	Net margin	-34,032.3%	Net Income: -826985 Open source Revenue: 2430 Open source
20152015-12-31	Net margin	-299,859%	Net Income: -467780 Open source Revenue: 156 Open source
20162016-12-31	Net margin	Not reported	Net Income: -397994 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: 869139 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -736850 Open source Revenue: 0 Open source
20192019-12-31	Net margin	Not reported	Net Income: -621920 Open source Revenue: 0 Open source
20202020-12-31	Net margin	Not reported	Net Income: -252734 Open source Revenue: 0 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 19085 Open source Operating Cash Flow: -427379 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 15236 Open source Operating Cash Flow: -182101 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 6113 Open source Operating Cash Flow: -149532 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 2430 Open source Operating Cash Flow: -291911 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 156 Open source Operating Cash Flow: -226378 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -94643 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -150613 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -257920 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -191673 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -74923 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -74.9K 2020

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Operating cash flow	-427379	Operating Cash Flow: -427379 Open source
20122012-12-31	Operating cash flow	-182101	Operating Cash Flow: -182101 Open source
20132013-12-31	Operating cash flow	-149532	Operating Cash Flow: -149532 Open source
20142014-12-31	Operating cash flow	-291911	Operating Cash Flow: -291911 Open source
20152015-12-31	Operating cash flow	-226378	Operating Cash Flow: -226378 Open source
20162016-12-31	Operating cash flow	-94643	Operating Cash Flow: -94643 Open source
20172017-12-31	Operating cash flow	-150613	Operating Cash Flow: -150613 Open source
20182018-12-31	Operating cash flow	-257920	Operating Cash Flow: -257920 Open source
20192019-12-31	Operating cash flow	-191673	Operating Cash Flow: -191673 Open source
20202020-12-31	Operating cash flow	-74923	Operating Cash Flow: -74923 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -427379 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -182101 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -149532 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: -291911 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -226378 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -94643 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -150613 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -257920 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -191673 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -74923 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

4,395.8% 2020

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Liabilities / assets	77%	Total Liabilities: 451148 Open source Total Assets: 586235 Open source
20122012-12-31	Liabilities / assets	180.1%	Total Liabilities: 853566 Open source Total Assets: 474027 Open source
20132013-12-31	Liabilities / assets	273.4%	Total Liabilities: 1087817 Open source Total Assets: 397947 Open source
20142014-12-31	Liabilities / assets	347.7%	Total Liabilities: 1705454 Open source Total Assets: 490512 Open source
20152015-12-31	Liabilities / assets	499.5%	Total Liabilities: 1790726 Open source Total Assets: 358521 Open source
20162016-12-31	Liabilities / assets	889.5%	Total Liabilities: 1891106 Open source Total Assets: 212607 Open source
20172017-12-31	Liabilities / assets	153.9%	Total Liabilities: 2140354 Open source Total Assets: 1390803 Open source
20182018-12-31	Liabilities / assets	358.9%	Total Liabilities: 2088189 Open source Total Assets: 581788 Open source
20192019-12-31	Liabilities / assets	1,649.5%	Total Liabilities: 2265672 Open source Total Assets: 137351 Open source
20202020-12-31	Liabilities / assets	4,395.8%	Total Liabilities: 2436483 Open source Total Assets: 55428 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2020

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Current assets / current liabilities	0.76×	Current Assets: 311408 Open source Current Liabilities: 407148 Open source
20122012-12-31	Current assets / current liabilities	0.29×	Current Assets: 237666 Open source Current Liabilities: 809566 Open source
20132013-12-31	Current assets / current liabilities	0.15×	Current Assets: 157570 Open source Current Liabilities: 1043817 Open source
20142014-12-31	Current assets / current liabilities	0.16×	Current Assets: 259800 Open source Current Liabilities: 1663683 Open source
20152015-12-31	Current assets / current liabilities	0.08×	Current Assets: 137474 Open source Current Liabilities: 1751296 Open source
20162016-12-31	Current assets / current liabilities	0.02×	Current Assets: 28785 Open source Current Liabilities: 1855460 Open source
20172017-12-31	Current assets / current liabilities	0.42×	Current Assets: 890803 Open source Current Liabilities: 2140354 Open source
20182018-12-31	Current assets / current liabilities	0.17×	Current Assets: 359788 Open source Current Liabilities: 2088189 Open source
20192019-12-31	Current assets / current liabilities	0.06×	Current Assets: 137351 Open source Current Liabilities: 2265672 Open source
20202020-12-31	Current assets / current liabilities	0.02×	Current Assets: 55428 Open source Current Liabilities: 2436483 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2011 2011-01-01 – 2011-12-31	−USD 783,616 Exact value Exact value: -783616 USD 2011-01-01 – 2011-12-31: -783616 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2011-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -783616 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -783616 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588913000747/qtxb-20121231.xml#64814 Filing: 000141588913000747 The citation records this snapshot. The page link may show a newer release later.	−USD 427,379 Exact value Exact value: -427379 USD 2011-01-01 – 2011-12-31: -427379 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2011-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -427379 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -427379 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588913000747/qtxb-20121231.xml#73568 Filing: 000141588913000747 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 717,967 Exact value Exact value: -717967 USD 2012-01-01 – 2012-12-31: -717967 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2012-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -717967 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -717967 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588914001167/qtxb-20131231.xml#83429 Filing: 000141588914001167 The citation records this snapshot. The page link may show a newer release later.	−USD 182,101 Exact value Exact value: -182101 USD 2012-01-01 – 2012-12-31: -182101 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2012-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -182101 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -182101 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588914001167/qtxb-20131231.xml#90610 Filing: 000141588914001167 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 358,331 Exact value Exact value: -358331 USD 2013-01-01 – 2013-12-31: -358331 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2013-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -358331 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -358331 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588915001361/qtxb-20141231.xml#59614 Filing: 000141588915001361 The citation records this snapshot. The page link may show a newer release later.	−USD 149,532 Exact value Exact value: -149532 USD 2013-01-01 – 2013-12-31: -149532 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2013-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -149532 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -149532 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588915001361/qtxb-20141231.xml#125983 Filing: 000141588915001361 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 826,985 Exact value Exact value: -826985 USD 2014-01-01 – 2014-12-31: -826985 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2014-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -826985 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -826985 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588916005518/qtxb-20151231.xml#98708 Filing: 000141588916005518 The citation records this snapshot. The page link may show a newer release later.	−USD 291,911 Exact value Exact value: -291911 USD 2014-01-01 – 2014-12-31: -291911 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2014-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -291911 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -291911 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000141588916005518/qtxb-20151231.xml#167160 Filing: 000141588916005518 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 467,780 Exact value Exact value: -467780 USD 2015-01-01 – 2015-12-31: -467780 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2015-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -467780 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -467780 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495417003379/qtxb-20161231.xml#45217 Filing: 000165495417003379 The citation records this snapshot. The page link may show a newer release later.	−USD 226,378 Exact value Exact value: -226378 USD 2015-01-01 – 2015-12-31: -226378 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2015-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -226378 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -226378 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495417003379/qtxb-20161231.xml#50240 Filing: 000165495417003379 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 397,994 Exact value Exact value: -397994 USD 2016-01-01 – 2016-12-31: -397994 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2016-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -397994 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -397994 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495418004035/qtxb-20171231.xml#47238 Filing: 000165495418004035 The citation records this snapshot. The page link may show a newer release later.	−USD 94,643 Exact value Exact value: -94643 USD 2016-01-01 – 2016-12-31: -94643 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2016-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -94643 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -94643 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495418004035/qtxb-20171231.xml#54546 Filing: 000165495418004035 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	USD 869,139 Exact value Exact value: 869139 USD 2017-01-01 – 2017-12-31: 869139 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2017-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: 869139 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 869139 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495419004468/qtxb-20181231.xml#33599 Filing: 000165495419004468 The citation records this snapshot. The page link may show a newer release later.	−USD 150,613 Exact value Exact value: -150613 USD 2017-01-01 – 2017-12-31: -150613 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2017-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -150613 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -150613 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495419004468/qtxb-20181231.xml#221572 Filing: 000165495419004468 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 736,850 Exact value Exact value: -736850 USD 2018-01-01 – 2018-12-31: -736850 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2018-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -736850 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -736850 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495420004054/qtxb-20191231.xml#40664 Filing: 000165495420004054 The citation records this snapshot. The page link may show a newer release later.	−USD 257,920 Exact value Exact value: -257920 USD 2018-01-01 – 2018-12-31: -257920 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2018-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -257920 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -257920 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495420004054/qtxb-20191231.xml#44620 Filing: 000165495420004054 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 621,920 Exact value Exact value: -621920 USD 2019-01-01 – 2019-12-31: -621920 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2019-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -621920 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -621920 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495421004257/qtxb-20201231.xml#42978 Filing: 000165495421004257 The citation records this snapshot. The page link may show a newer release later.	−USD 191,673 Exact value Exact value: -191673 USD 2019-01-01 – 2019-12-31: -191673 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2019-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -191673 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -191673 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000165495421004257/qtxb-20201231.xml#47318 Filing: 000165495421004257 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 252,734 Exact value Exact value: -252734 USD 2020-01-01 – 2020-12-31: -252734 USD Inspect Net Income Open source Share or cite Citation for Net Income · QUANTRX BIOMEDICAL CORPORATION · 2020-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Net Income: -252734 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -252734 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000149315222010071/form10-k.htm#656491 Filing: 000149315222010071 The citation records this snapshot. The page link may show a newer release later.	−USD 74,923 Exact value Exact value: -74923 USD 2020-01-01 – 2020-12-31: -74923 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · QUANTRX BIOMEDICAL CORPORATION · 2020-12-31 QUANTRX BIOMEDICAL CORPORATION (edgar:820608) Operating Cash Flow: -74923 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:24:48Z Snapshot: b092398570bb31fbd0770ba96f2cb8452946882e4805541e862358c56323e98e Dimensions: Consolidated View: https://fundies.io/companies/edgar/820608/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -74923 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/820608/000149315222010071/form10-k.htm#607886 Filing: 000149315222010071 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

121 filings · 2,459 latest values · 2,459 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000820608, 820608, QTXB, edgar:820608

Also known as AFEM MEDICAL CORP, ATHENA MEDICAL CORP, QUANTRX BIOMEDICAL CORPORATION, QUANTRX BIOMEDICAL CORPORATION, QUANTRX BIOMEDICAL CORP, QUANTRX BIOMEDICAL CORPORATION

QUANTRX BIOMEDICAL CORPORATION

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2020 2020-01-01 – 2020-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation